News items related to: Malaysia

Posted September 11, 2018 by ITPC

ITPC is delighted to be named one of three successful grantees of a new three year investment from Unitaid to...

Read more about Unitaid investment expands our work on access to medicines

Posted April 3, 2018 by ITPC

From Hollywood blockbusters, to investigative documentaries, to our own short, satirical animation, here are eight videos that show how the...

Read more about 8 videos that explain the tension between HIV activists and Big Pharma

Posted February 23, 2018 by ITPC

Marrakech was home to the signing of the TRIPS Agreement in 1995, an agreement that has been exploited by pharmaceutical...

Read more about Fixing the broken patent system: From Marrakech and back again

Posted January 30, 2018 by ITPC

[View the story “Pathways to Access! #GSIPA2M (15-17 Jan 2018)” on Storify] SaveSave

Read more about Storify: Pathways to Access #GSIPA2M

Posted January 19, 2018 by ITPC

Catch up on the activity from our inaugural Global Summit on Intellectual Property and Access to Medicines (15-17 January 2018)....

Read more about GSIPA2M: The Summit Highlights

Posted January 18, 2018 by ITPC

Malaysia’s “historic decision” to issue a compulsory license on Hep C medicine, sofosbuvir, stands up to Big Pharma, and will mean...

Read more about GSIPA2M: Malaysia Ministry of Health 2018 winner of the Leadership Award on Intellectual Property and Access to Medicines

Posted September 20, 2017 by ITPC

Historic decision will cure more hepatitis C patients – and other countries can follow suit. Today, 20 September 2017, Malaysia’s...

Read more about Malaysia paves the way for compulsory licensing on hepatitis C medicines 

Posted August 24, 2017 by ITPC

With new, revolutionary, drugs available, why isn’t everyone getting the cure? An estimated 454,000 people are living with hepatitis C...

Read more about Tackling the hepatitis C epidemic in Malaysia